Atrial Fibrillation and Risk of ST-Segment–Elevation Versus Non–ST-Segment–Elevation Myocardial Infarction: The Atherosclerosis Risk in Communities (ARIC) Study

Soliman, Elsayed Z., Lopez, Faye, O’Neal, Wesley T., Chen, Lin Y., Bengtson, Lindsay, Zhang, Zhu-Ming, Loehr, Laura, Cushman, Mary, Alonso, Alvaro·2015·Circulation
DOI 10.1161/circulationaha.114.014145

Cited by (173)

Items 101–173 of 173

  1. Use of Anticoagulant Therapy in Patients with Acute Myocardial Infarction and Atrial Fibrillation
    Ratko Lasica, Lazar Djukanovic, Dejana Popović, Lidija Savić, Igor Mrdović, Nebojša Radovanović, Mina Radovanović, Marija M. Polovina, Radan Stojanović, Dragan Matić et al. · 2022 · Medicina
  2. Trimetazidine combined with berberine on endothelial function of patients with coronary heart disease combined with primary hypertension
    Hui Zhang, Hongyu Niu, Xiangzhi Yuan, Jing Kai Chang, Xiaojuan Wang · 2018 · Experimental and Therapeutic Medicine
  3. Outcomes of Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention Analysis of National Inpatient Sample
    Madhan Shanmugasundaram, Bishnu Prasad Dhakal, Sangeetha Murugapandian, Mehrtash Hashemzadeh, Timir Kumar Paul, Mohammed Reza Movahed · 2019 · Cardiovascular revascularization medicine
  4. Direct oral anticoagulants and cardiovascular prevention in patients with nonvalvular atrial fibrillation
    Francisco R. Marín, Manuel P. Anguita-Sánchez, Marcelo Sanmartı́n · 2016 · Expert Opinion on Pharmacotherapy
  5. Atrial Fibrillation in Critical Illness
    Evin Yucel, Steven M. Hollenberg · 2015 · Critical Care Medicine
  6. Integrative identification of hub genes in development of atrial fibrillation related stroke
    Kai Huang, Xi Fan, Yuwen Jiang, Sheng Jin, Jiechun Huang, Liewen Pang, Yiqing Wang, Yuming Wu, Xiaotian Sun · 2023 · PLoS ONE
  7. Outcomes and predictive value of the 2MACE score in patients with atrial fibrillation treated with rivaroxaban in a prospective, multicenter observational study: The EMIR study
    Marcelo Sanmartı́n, Manuel Anguita Sánchez, Fernando Arribas, Gonzalo Barón‐Esquivias, Vivencio Barrios, Juan Cosı́n-Sales, María Asunción Esteve‐Pastor, Román Freixa‐Pamias, Iñaki Lekuona, Alejandro Pérez Cabeza et al. · 2022 · Cardiology Journal
  8. Should atrial fibrillation be considered a vascular disease? The need for a comprehensive vascular approach
    Carlos Escobar-Cervantes, Antonio Pose Reino, Pablo Díez‐Villanueva, Lorenzo Fácila, Román Freixa‐Pamias, Alfonso Valle, Manuel Almendro‐Delia, Clara Bonanad, David Vivas, Carmen Suárez · 2023 · Expert Review of Cardiovascular Therapy
  9. Drug Persistence and Outcomes in a Cohort of Patients With Nonvalvular Atrial Fibrillation Treated With Rivaroxaban After 2 Years of follow-up in Clinical Practice
    Alejandro Pérez Cabeza, José Antonio González Correa, Pedro Antonio Chinchurreta Capote, Rafael Bravo Marqués, Francisco Ruíz Mateas, Gabriel Rosas Cervantes, Fidel Ernesto Mesa Prado, Sergio López‐Tejero, Almudena Valle Alberca · 2018 · Future Cardiology
  10. Associations between cardiac arrhythmias and cardiovascular disease incidence and all-cause mortality: the Kailuan study
    Xuemei Yang, Tingting Geng, Yinshun Peng, Liufu Cui, Shuohua Chen, Guodong Wang, Xiang Gao, Shou-ling Wu · 2024 · BMC Public Health
  11. California Study of Ablation for Atrial Fibrillation:Re-hospitalization for Cardiac Events (CAABL-CE)
    Uma Narasimhan Srivatsa · 2018 · Journal of Atrial Fibrillation
  12. Autonomic modulation before and after paroxysmal atrial fibrillation events in patients with ischemic heart disease
    Ting‐Wei Ernie Liao, Li‐Wei Lo, Yenn‐Jiang Lin, Shih‐Lin Chang, Yu‐Feng Hu, Cheng‐I Wu, Fa‐Po Chung, Tze‐Fan Chao, Jo‐Nan Liao, Shih‐Ann Chen · 2020 · Annals of Noninvasive Electrocardiology
  13. Long-Term Outcomes for Patients With Acute Coronary Syndrome and Nonvalvular Atrial Fibrillation
    Pishoy Gouda, Douglas C. Dover, Anamaria Savu, Kevin R. Bainey, Shaun G. Goodman, Robert C. Welsh, Padma Kaul, Roopinder Kaur Sandhu · 2022 · The American Journal of Cardiology
  14. Tactics of Selection of Anticoagulant Therapy in Patients With Atrial Fibrillation and Ischemic Heart Disease
    Yu. N. Belenkov, Шакарьянц Гаянэ Андрониковна, Natalia V. Khabarova · 2018 · Kardiologiia
  15. Oral anticoagulant therapy for patients with new-onset atrial fibrillation following acute myocardial infarction: A narrative review
    Shenglong Yu, Chenxi Li, Huizhuang Guo · 2022 · Frontiers in Cardiovascular Medicine
  16. Use of the CHA2DS2-VASc score to predict subsequent myocardial infarction in atrial fibrillation
    Su‐Kiat Chua, Pang‐Shuo Huang, Jien‐Jiun Chen, Fu‐Chun Chiu, Juey‐Jen Hwang, Chia‐Ti Tsai · 2023 · Hellenic Journal of Cardiology
  17. NSTEMI mortality and hospital outcomes in patients with atrial fibrillation: A propensity score-matched analysis
    Mirza Faris Ali Baig · 2024 · IJC Heart & Vasculature
  18. Trends in the Incidence and In-Hospital Outcomes of Patients With Atrial Fibrillation Complicated by Non-ST-Segment Elevation Myocardial Infarction
    Gbolahan O. Ogunbayo, Adrian W. Messerli, Le Dung Ha, Ayman Elbadawi, Odunayo E. Olorunfemi, Yousef Darrat, Maya E. Guglin, Remi T. Okwechime, Deborah Tosin Akanya, Ahmed Abdel‐Latif et al. · 2018 · Angiology
  19. Utilization of triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention
    Hye-Jeong Choi, Yonghyuk Lee, Susin Park, Nam Kyung Je · 2023 · European Journal of Clinical Pharmacology
  20. CHA2DS2-VASc Score, Mortality and Acute Myocardial Infarction in Patients With Nonvalvular Atrial Fibrillation
    Mustafa Gabarin, Tzipi Hornik‐Lurie, Sa’ar Minha, Alexander Omelchenko, Rami Barashi, Ziad Arow, Abid Assali, David Pereg · 2022 · The American Journal of Cardiology
  21. Uptake of evidence-based statin therapy among atrial fibrillation patients in China: A report from the CAFR (Chinese Atrial Fibrillation Registry) Study
    Shijun Xia, Xin Du, Chao Li, Jiahui Wu, Ribo Tang, Sanshuai Chang, Xueyuan Guo, Ronghui Yu, Deyong Long, Rong Bai et al. · 2016 · International Journal of Cardiology
  22. Effects of Prevalent and Incident Chronic Kidney Disease on Cardiovascular Events in Patients with Atrial Fibrillation
    Hsuan-Yu Lin, Chew‐Teng Kor, Yao‐Peng Hsieh, Ping‐Fang Chiu · 2019 · Journal of Clinical Medicine
  23. New-Onset Atrial Fibrillation Before Or After Myocardial Infarction, Which Is Worse for Mortality?
    Eitaro Kodani · 2023 · The American Journal of Cardiology
  24. Relationship between myocardial infarction and atrial fibrillation: A bidirectional Mendelian randomization study
    Jin Rao, Yue Yu, Pengchao Cheng, Xuefu Wang, Pei Wang, Zhinong Wang · 2024 · Medicine
  25. Risk of Coronary Events in Atrial Fibrillation
    Zhanna D. Kobalava, Pavel V. Lazarev · 2020 · Kardiologiia
  26. Clinical and pathogenetic features of myocardial infarction in patients with atrial fibrillation
    Бородашкина Светлана Юрьевна, Константин Викторович Протасов · 2020 · Siberian medical review
  27. Association of chronic kidney disease with all-cause mortality in patients hospitalized for atrial fibrillation and impact of clinical and socioeconomic factors on this association
    Min-qiang Bao, Gui-jun Shu, Chuan-jin Chen, Yi-nong Chen, Jie Wang, Yu Wang · 2022 · Frontiers in Cardiovascular Medicine
  28. Correlation between thromboembolic risk and prevalence of coronary artery disease in patients with atrial fibrillation and impaired renal function
    T. Murakami, A. Yagishita, K. Ayabe, Susumu Sakama, Kyong Hee Lee, M. Amino, K. Yoshioka, Y. Ikari · 2024 · International Journal of Cardiology: Heart & Vasculature
  29. Atrial Fibrillation
    Ziad F. Issa, John M. Miller, Douglas Peter Zipes · 2019 · Elsevier eBooks
  30. Impact of heart failure on the clinical profile and outcomes in patients with atrial fibrillation treated with rivaroxaban. Data from the EMIR study
    Manuel Anguita Sánchez, Francisco R. Marín, Jaime Masjuán, Juan Cosı́n-Sales, José Manuel Vázquez‐Rodríguez, Vivencio Barrios, Gonzalo Barón‐Esquivias, Iñaki Lekuona, Alejandro Pérez Cabeza, Román Freixa‐Pamias et al. · 2022 · Cardiology Journal
  31. Incidence of Atrial Fibrillation and Related Outcomes among Hospitalized Patients with Systemic Lupus Erythematosus: Analysis of United States Nationwide Inpatient Sample Database 2016–2019
    Sushmita Mittal, Chokkalingam Siva · 2024 · Journal of Clinical Medicine
  32. Physiological function of cyclic nucleotide phosphodiesterases in atrial myocytes and their potential as therapeutic targets for atrial fibrillation
    Matthew J. Read, Andreas Koschinski, Samuel J. Bose, Rebecca A.B. Burton · 2025 · American Journal of Physiology-Cell Physiology
  33. Atrial fibrillation and its relation to cardiac diseases and sudden cardiac death
    Jiřı́ Šmı́d, Richard Rokyta · 2017 · Cor et Vasa
  34. Current Use of Oral Anticoagulants and Prognostic Analysis in Patients with Atrial Fibrillation Undergoing Coronary Stenting
    Heng-Bo Zhai, Jun Liu, Zhichao Dong, Dongxia Wang, Bo Zhang · 2017 · Chinese Medical Journal
  35. Potential for anticoagulant therapy in the most vulnerable groups of patients
    Irina A. Zolotovskaya, Victoria D. Sabanova, Igor L. Davydkin · 2021 · Russian Journal of Cardiology
  36. A simple APACHE IV risk dynamic nomogram that incorporates early admitted lactate for the initial assessment of 28-day mortality in critically ill patients with acute myocardial infarction
    Jikai Song, Tianhang Yu, Qiqi Yan, Liuyang Wu, Sujing Li, Lihong Wang · 2022 · BMC Cardiovascular Disorders
  37. Atrial fibrillation increases the risk of new-onset myocardial infarction amongst working-age population: a propensity-matched study
    Bocheng Yue, Qiqi Hou, Julian Bredehorst, Quanle Han, Boheng Zhang, Chao Zhang, Jiawei Zhang, Shuohua Chen, Shouling Wu, Kangbo Li · 2023 · Herz
  38. Atrial fibrillation increases risk of NSTEMI
    Gregory B. Lim · 2015 · Nature Reviews Cardiology
  39. Who Benefits Most From Early Rhythm Control in Newly Diagnosed Atrial Fibrillation?
    Eunice Yang, Hugh G Calkins · 2022 · Circulation
  40. Echo-cardiographic parameters for atrial fibrillation in combination with acute coronary syndrome in real clinical practice according to register of acute coronary syndrome in the Krasnodar region
    З. Г. Татаринцева, E. D. Kosmacheva, V. A. Porhanov, С. В. Кручинова · 2019 · CARDIOVASCULAR THERAPY AND PREVENTION
  41. 2021 Korean Heart Rhythm Society Guidelines: Management of Atrial Fibrillation in Specific Clinical Settings
    You Mi Hwang, Hong Euy Lim, Dae In Lee, Hee Tae Yu, Yae Min Park, Boyoung Joung · 2021 · Korean Journal of Medicine
  42. Measurement of myocardial blood flow in atrial fibrillation using high-resolution, free-breathing in-line quantitative cardiovascular magnetic resonance
    Richard Crawley, Karl Kunze, Anmol Kaushal, Xenios Milidonis, Jack Highton, Blanca Domènech-Ximenos, Irum Kotadia, Can Karamanli, Nathan Wong, Robbie Murphy et al. · 2025 · Journal of Cardiovascular Magnetic Resonance
  43. Dysregulation of adipocytokines via the hsa-miR-548ay-3p/PPARγ signaling pathway leads to cardiac fibrosis
    Yubin Chen, Cheng Fang, Wei Liu, Kaibo Lei, Ping Hu, Can‐E Tang, Lin Wang, Fanyan Luo · 2025 · Scientific Reports
  44. Atrial fibrillation and acute myocardial infarction: a Two-Way relationship
    Arianna Pannunzio, Flavio Mastroianni, Laura Gatto, Pasquale Pignatelli, Francesco Prati, Daniele Pastori, Danilo Menichelli, Flavio Giuseppe Biccirè · 2026 · Frontiers in Cardiovascular Medicine
  45. Blood Biomarkers and the Risk of Coronary Disease in Atrial Fibrillation
    Andres M. Cordova Sanchez, Katherine S. Wilkinson, Samuel Short, Virginia J. Howard, Suzanne E. Judd, Parag Goyal, Elsayed Z. Soliman, Emily B. Levitan, Monika M. Safford, Mary Cushman · 2026 · Journal of the American Heart Association
  46. Atrial fibrillation and risk of myocardial infarction by sex and time since diagnosis. The Tromsø Study 1994–2021
    Linn Nilsen, Ekaterina Sharashova, Maja‐Lisa Løchen, Jan Mannsverk, Tom Wilsgaard · 2026 · European Heart Journal - Quality of Care and Clinical Outcomes
  47. Sex-Based Disparities in Health Care Access and Utilization Among Patients With Atrial Fibrillation
    Ji Mei May Wong, Peter Russell Kowey · 2026 · JAMA Network Open
  48. Current ideas of a complex relationship between atrial fibrillation and ischemic heart disease and of optimum tactics for anticoagulant therapy to prevent embolism in systemic circulation
    S. R. Gilyarevskiy, Maria V. Golshmid, Irina M. Kuzmina, Irina I. Sinitsina · 2017 · Kardiologiia
  49. Management of Complications in Anticoagulated Patients with Atrial Fibrillation
    George Katritsis, Demosthenes G. Katritsis · 2017 · Arrhythmia & Electrophysiology Review
  50. Atrial fibrillation and troponin elevation: It's time to give up the chase to diagnosis and step forward with prognosis
    Francesco Notaristefano, Claudio Cavallini · 2022 · European Journal of Internal Medicine
  51. Atrial fibrillation in non-ST-elevation myocardial infarction patients – worse clinical presentation and adverse long term prognosis
    Marcin Kamil Dobrowolski, Ilona Kowalik, Krzysztof Jaworski, Michał M. Farkowski, Rafał Dąbrowski · 2025 · Polski Merkuriusz Lekarski
  52. Renal function and outcome of patients with non-valvular atrial fibrillation
    Rami Barashi, Tzipi Hornik‐Lurie, Hagit Gabay, Feras Haskiah, Sa’ar Minha, Mony Shuvy, Abid Assali, David Pereg · 2021 · European Heart Journal Acute Cardiovascular Care
  53. Variability of arterial hypertension as an additional factor to cardiovascular risk in atrial fibrillation
    N. Ya. Dotsenko, L. V. Herasymenko, I.A. Shekhunova, С. С. Боев, А. В. Молодан, A. Ya. Malinovskaya, O. V. Yatsenko · 2021 · Modern medical technology
  54. Gender and atrial fibrillation: revisiting its role in integrated ABC pathway management
    Eka Prasetya Budi Mulia · 2022 · Heart and Vessels
  55. Fibrilación auricular y cardiopatía isquémica: más allá de la prevención del ictus
    Eduardo Alegría Ezquerra, Rosa Agra Bermejo, Luis Javier Alonso Perez, Miguel Ángel Fernández Fernández, José Manuel Vázquez‐Rodríguez, Óscar Díaz Castro, Marisol Bravo Amaro, Ramón Ríos Vázquez, Julio Martí‐Almor · 2020 · Revista Española de Cardiología Suplementos
  56. Demographics and procedural data differences of AF ablation
    Elisabetta Toso, Mattia Peyracchia, Roberto Di Summa, Carla Giustetto, Fiorenzo Gaïta · 2020 · Elsevier eBooks
  57. VARIABILITY OF BLOOD PRESSURE IN COMORBIDITY OF ARTERIAL HYPERTENSION AND ATRIAL FIBRILLATION
    С. С. Боев, N. Ya. Dotsenko, I.A. Shekhunova, L. V. Herasymenko, O. V. Yatsenko, D. Yu. Lyubitov · 2021 · Journal of the Grodno State Medical University
  58. Prevention of Atrial Fibrillation
    Jelena Kornej, Emelia J. Benjamin · 2020 · Contemporary cardiology
  59. Rivaroxaban for the prevention of outcomes in patients with atrial fibrillation in clinical practice: an indirect comparison of national and international registries
    Francisco R. Marín, Marcelo Sanmartı́n, Iñaki Lekuona, Fernando Arribas, Gonzalo Barón‐Esquivias, Vivencio Barrios, Juan Cosı́n-Sales, Román Freixa‐Pamias, Jaime Masjuán, Alejandro Pérez Cabeza et al. · 2022 · Journal of Comparative Effectiveness Research
  60. Causal association between myocardial infarction and atrial fibrillation: A bidirectional Mendelian randomization study
    Jin Rao, Zhinong Wang · 2023 · Research Square
  61. The Trend of Ischemic Evaluation, Intervention, and In-Hospital Mortality and Outcomes among Patients with Acute Myocardial Infarction and Atrial Fibrillation
    Mirza Faris Ali Baig · 2023 · medRxiv
  62. Artificial intelligence techniques for diagnosis of atrial fibrillation
    Arya Bhardwaj, Rajeswari Bandyopadhyay, R. Pradeep Kumar, Bala Chakravarthy Neelapu, Kunal Pal, J. Sivaraman · 2024 · Elsevier eBooks
  63. Clinical profile and outcomes in very elderly patients with atrial fibrillation anticoagulated with rivaroxaban: data from the EMIR study
    Francisco R. Marín, Manuel Anguita Sánchez, Iñaki Lekuona, Marcelo Sanmartı́n, Vivencio Barrios, Carlos Pérez Muñoz, Juan Cosı́n-Sales, Alejandro Pérez Cabeza, Vanesa Roldán Schilling, Carles Ràfols et al. · 2024 · 老年心脏病学杂志：英文版
  64. Gender specific aspects of digital screening for atrial fibrillation: insights from the randomized eBRAVE-AF trial
    Luisa Freyer, Peter Spielbichler, Lukas von Stülpnagel, Konstantinos Mourouzis, Lukas Tenbrink, Laura Elisa Villegas Sierra, Maria F Vogl, Lauren Eleonore Sams, Annika Schneidewind, Mathias Klemm et al. · 2025 · European Heart Journal - Digital Health
  65. Olfaction and Coronary Heart Disease
    Keran W. Chamberlin, Chenxi Li, Anna Kucharska‐Newton, Zhehui Luo, Mathew J. Reeves, Srishti Shrestha, Jayant Marian Pinto, Jennifer A. Deal, Vidyulata J. Kamath, David J. Couper et al. · 2025 · JAMA Otolaryngology–Head & Neck Surgery
  66. Additional file 1 of A simple APACHE IV risk dynamic nomogram that incorporates early admitted lactate for the initial assessment of 28-day mortality in critically ill patients with acute myocardial infarction
    Song, Jikai, Tianhang Yu, Yan, Qiqi, Wu, Liuyang, Li, Sujing, Wang, Lihong · 2022 · Figshare
  67. Prognostic Impact of New‐Onset Atrial Fibrillation After Cardiac Arrest: Observations From a Federated Research Network
    Enrico Tartaglia, Tommaso Bucci, Amir Askarinejad, Michele Rossi, Muath Alobaida, Steven Ho Man Lam, Mert Kaşkal, Andrea Galeazzo Rigutini, Shir Lynn Lim, Giuseppe Boriani et al. · 2026 · Journal of Cardiovascular Electrophysiology
  68. Long-term incidence of atrial fibrillation and cardiovascular outcomes in men and women with sinus rhythm: a 20-year follow-up of the INTERGENE population-based cohort
    Adam Viktorisson, Ilham A AlKhatib, Muwada Bashir Awad Bashir, Fredrik Nyberg, Lauren Lissner, Dag Steinar Thelle · 2026 · Open Heart
  69. Late-Life Incident Stroke in the Atherosclerosis Risk in Communities Study: Etiology and Prediction
    Jing Wang, Marco S. Egle, Zhenghao Jin, Kamakshi Lakshminarayan, Chiadi E. Ndumele, Josef Coresh, Rebecca F. Gottesman, Michelle C. Johansen · 2026 · Stroke
  70. Timing of New-Onset Atrial Fibrillation After Myocardial Infarction: Prognostic Impact and Associated Clinical Characteristics
    Carl Ammoury, Shivabalan Kathavarayan Ramu, Judah Rajendran, Besir Besir, Alexander Michael Egoavil, Sada babazade, Wajeeh Abu Rmeileh, Tamari Lomaia, Taha Hatab, Vaidehi Alkeshbhai Mendpara et al. · 2026 · The American Journal of Cardiology
  71. Compliance with the ABC pathway for integrated care of patients with atrial fibrillation in Brazil: a retrospective cohort study
    Itamar S Santos, Alessandra Carvalho Goulart, Rodrigo Díaz Olmos, Ana C Varella, Carla Romagnolli, Otávio Gebara, Ana TA Lopes, Flávia Ppl Lopes, Tiffany E Gooden, G. Neil Thomas et al. · 2026 · Expert Review of Cardiovascular Therapy
  72. Atrial Fibrillation in Patients With Myocardial Infarction: Global Burden, Predictors, and Prognostic Impact
    Eddy Xiong, Sandhir B. Prasad, John James Atherton, Jason Davis, Paul Martin, Daniel V. Lancini · 2026 · Pacing and Clinical Electrophysiology
  73. Cardiovascular Health and Healthy Aging
    BHAVANI ANANTHARAMAKRISHNAN, Jacob Obholz, Somto Tagbo Nwaedozie, Manish Kumar · 2026 · Springer eBooks